QUINCE THERAPEUTICS INC (QNCX)

US22053A1079 - Common Stock

0.95  +0.03 (+3.26%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
28.72M51.19M90.32M78.89M39.17M
Research and Development
9.45M25.18M60.80M61.31M30.21M
Selling, General, and Administrative Expenses
17.70M26.01M29.52M17.59M8.95M
Operating Income
-28.72M-51.19M-90.32M-78.89M-39.17M
Interest Income/Expense
3.48M1.07M620.00K2.04M2.19M
Other Income/Expense
-440.00K-1.00M-250.00KN/AN/A
Non Recurring Items
-5.90M-830.00KN/AN/AN/A
Income Before Taxes
-31.58M-51.94M-89.95M-76.85M-36.98M
Income Tax
-197.00K-280.00KN/AN/AN/A
Net Income
-31.39M-51.66M-89.95M-76.85M-36.98M
EBITDA
-28.40M-50.99M-89.98M-78.56M-38.98M
 
Per Share Data
EPS Diluted Total Ops
-0.84-1.54-3.03-2.63-1.94
Non GAAP EPS
N/AN/A-3.03-2.63-2.90
 
Statistics

All data in USD

Charts